http://web.archive.org/web/20100809235005id_/http://www.cnn.com:80/2010/HEALTH/05/27/medicine.recall.hearing/

@entity0 -- lawmakers have scheduled a hearing thursday to look into the recall of popular pediatric medicines by drugmaker @entity6 , which has initiated four recalls of its products in the past seven months			1
among those testifying will be @entity10 , the worldwide chairman of @entity11 , of which @entity6 is a division			2
the @entity14 also invited @entity11 and @entity11 chief executive @entity15 , but he declined to attend because of health reasons			0
a panel of @entity19 officials will also be at the hearing			0
the recalls include popular over-the - counter drugs such as @entity23 , @entity24 and @entity25			1
more information on recalled products fifty children 's versions of these nonprescription medicines were also recalled on may 1 because of quality and safety concerns			1
@entity6 has maintained that its recall of the children 's drugs was not " undertaken on the basis of adverse medical events " but as a precautionary measure			1
adverse event reports are consumer complaints of a serious side effect associated with the use of a medical product , according to the @entity19			0
adverse events could include death , hospitalization , disability and other health complications			0
following the pediatric medicine recall , @entity11 and @entity11 suspended production at @entity6 's facility in @entity0 , @entity53 that manufactured the children 's drugs			1
on tuesday , the drugmaker outlined steps to remedy serious quality and safety lapses at the @entity0 plant and its other manufacturing facilities			1
" @entity6 is taking steps to bring its operation back to a level of quality that @entity11 and @entity11 demands of its companies , and that the public rightly expects of us , and that we expect of ourselves , " the company said in a statement			2
among the measures , the drugmaker said it has hired an independent pharmaceutical consulting firm to identify corrective actions to improve quality and manufacturing systems at its @entity0 facility			0
@entity6 did not say when it would resume production at the plant			0
regarding its products , @entity6 said it will conduct in - depth quality assessments for each product that the company manufactures to " ensure each product 's ability to meet specifications throughout its shelf life			2
" the company also said it will update the @entity19 about its progress implementing the plan at least once a month and would involve an independent firm in making product decisions during the first six months of operation			0
@entity6 's other recalls in the past seven months were : -- in november 2009 , five lots of @entity99 count with the @entity101 - open cap were recalled for unusual odor leading to nausea , stomach pain , vomiting and diarrhea			2
-- in december , the recall was expanded to include all product lots of @entity109 count bottles with the red @entity101 - open cap			0
-- in january 2010 , the recall was widened to an undisclosed number of @entity23 , @entity24 and other over-the - counter drugs after complaints of consumers feeling sick from an odor .			1

drug company has recalled products 4 times in 7 months
recalls include children 's version of @entity23 and @entity24
@entity11 and @entity11 shut down plant , outlines steps to remedy lapses
for more information on recalled products , go to the @entity133 recall site

@entity23:Tylenol
@entity1:CNN
@entity0:Fort Washington
@entity6:McNeil
@entity11:Johnson
@entity10:Colleen Goggins
@entity25:Benadryl
@entity15:William Weldon
@entity19:FDA
@entity53:Pennsylvania
@entity101:EZ
@entity14:House Committee on Oversight and Government Reform
@entity133:McNeill
@entity99:Tylenol Arthritis Pain 100
@entity109:Tylenol Arthritis Pain caplet 100
@entity24:Motrin